Facebook Twitter LinkedIn Google Plus RSS

PTC Therapeutics announces pricing of public offering

By ,

South Plainfield-based PTC Therapeutics Inc. announced Thursday the pricing of its public offering of 4.49 million shares of common stock at a price of $24.50 per share.

According to the release, J.P. Morgan and Credit Suisse are acting as joint lead book-running managers for the offering. Registration to these securities was declared effective by the Securities and Exchange Commission on Feb. 12.

ALSO ON NJBIZ:

Harrison Mayor McDonough remembered as a champion of redevelopment

Two N.J. companies earn spot on list of top 50 companies for women

Latest ACA enrollment numbers lower than expected

More From This Industry

Emily Bader

Emily Bader

Emily Bader is the copy and web editor at NJBIZ. She is a Brielle, N.J. native and a Rutgers University alum. You can contact her at emilyb@njbiz.com or @emilybader on Twitter.

Leave a Comment

test

Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy

Comments

close
Subscribe to Our Newsletters!
Click Here to Subscribe for Free Now!